Preclinical Imaging Market by Product (Modalities, Reagents), Application (Drug Discovery, Research & Development), End-User - Global Forecast 2024-2030

Preclinical Imaging Market by Product (Modalities, Reagents), Application (Drug Discovery, Research & Development), End-User - Global Forecast 2024-2030

The Preclinical Imaging Market size was estimated at USD 2.48 billion in 2023 and expected to reach USD 2.60 billion in 2024, at a CAGR 4.91% to reach USD 3.48 billion by 2030.

Preclinical imaging includes devices, software, and services used to image small animals in preclinical research, including mice and rats. Preclinical imaging uses various imaging techniques to visualize and study the anatomy, function, and metabolism of organs and tissues in small laboratory animals. These non-invasive techniques do not require surgical procedures to observe the body's internal workings. Key techniques include MRI, PET, SPECT, CT, optical imaging, and ultrasound, which provide critical insights for drug development, genetic research, cancer studies, neurological studies, and cardiovascular investigations. As pharmaceutical and biotechnology companies invest more in R&D, the need for precise and efficient preclinical imaging grows. The increasing need to understand and treat chronic diseases fuels the need for preclinical imaging in disease mechanism studies and drug development. Increasing investment in drug discovery and clinical trials necessitates robust preclinical testing, contributing to market growth. High cost and technical complexity associated with preclinical imaging hamper the market growth. Rising development of non-invasive techniques, enhancing image resolution, creating portable imaging systems, and applying these technologies to emerging fields, including regenerative medicine and immunotherapy, are expected to create opportunities for market growth.

Regional Insights

In the Americas, the market for preclinical imaging is propelled by substantial investments in pharmaceutical R&D, a strong presence of key market players, and robust academic and research institutions. South America is also showing promising growth, with countries including Brazil and Argentina investing more in healthcare infrastructure and research, supported by government initiatives and increasing collaborations with global pharmaceutical companies. The APAC region is witnessing rapid growth due to increasing healthcare expenditures, an expanding biotechnology sector, and a rising number of CROs catering to global pharmaceutical companies. Additionally, government initiatives to boost research infrastructure in countries including China and India further fuel the market. In the EMEA region, the market benefits from strong government support for research activities, established healthcare infrastructure, and collaborative efforts between academic institutions and industry players. Europe's focus on advanced medical research and the adoption of cutting-edge imaging technologies also contribute significantly to market growth in this region. In the Middle East, countries including Saudi Arabia and the UAE invest heavily in healthcare and research infrastructure, aiming to become regional medical research and innovation hubs. Africa is growing in the preclinical imaging market with increasing support for healthcare projects and partnerships with international organizations.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Preclinical Imaging Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

Increasing research & development activities by pharmaceutical companies
Growing government investment and funding for expanding biomedical research
Rising number of clinical research organizations (CROs)

Market Restraints

High cost of imaging equipment and maintenance of preclinical imaging

Market Opportunities

Increasing incorporation of advanced technologies in preclinical imaging to improve image analysis
Rising focus on the development of personalized medicines

Market Challenges

Strict regulations and ethical concerns associated with animal research

Market Segmentation Analysis

Product: Growing usage of modalities in preclinical studies for specific research needs
End-User: Increasing adoption of preclinical imaging by pharmaceutical & biopharmaceutical companies to develop new drugs

Market Disruption Analysis

Porter’s Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Preclinical Imaging Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Preclinical Imaging Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Revvity, Inc.’s Innovative Preclinical Imaging Solutions Unveiled at WMIC 2023

Revvity, Inc. unveiled an enhanced imaging portfolio aimed at revolutionizing preclinical research. Key innovations include the IVIS Spectrum 2 and IVIS SpectrumCT 2 systems, which set new benchmarks for in vivo optical imaging versatility and sensitivity. Additionally, the Quantum GX3 microCT offers heightened resolution and speed for comprehensive in vivo and ex vivo imaging, aiding researchers in disease biology and therapeutic evaluation.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Preclinical Imaging Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Preclinical Imaging Market, highlighting leading vendors and their innovative profiles. These include Advanced Molecular Vision, Inc., Angstrom Advanced Inc., Aspect Imaging Ltd., Berthold Technologies, Bruker Corporation, Euro-BioImaging ERIC, FUJIFILM Holdings America Corporation, IVIM Technology Corp., KUBTEC Technology, LI-COR, Inc., Mediso Ltd., Milabs BV, Miltenyi Biotec GmbH, MR Solutions Group, Peira bvba, PerkinElmer Inc., Revvity, Inc., Scitech Pty Ltd., and United Imaging Healthcare Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Preclinical Imaging Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
Modalities
Magnetic Particle Imaging
Magnetic Resonance Imaging
Micro-Computed Tomography
Optical Imaging
Positron Emission Tomography
Single-Photon Emission Computed Tomography
Reagents
Bioluminescent Imaging Reagents
Fluorescent Imaging Reagents
MRI Contrasting Reagents
PET Radioactive Tracers
Ultrasound Contrasting Reagents
X-ray CT Contrasting Reagents
Application
Drug Discovery
Research & Development
End-User
Academic & Government Research Institutes
Contract Research Organizations (CROs)
Pharmaceutical & Biotechnology Companies
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

Please Note: PDF & Excel + Online Access - 1 Year